Biological Products, (No Diagnostic Substances) · MI · CIK 887359
Vericel provides advanced cell therapies and specialty biologics for sports medicine and severe burn care
Comparable business profile · signals at a glance
In the 90 days to Mar 23, 2026: 4 sold $2.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Hagen HeidiDirector | Sell | 15,000 | $32.41 | $486K |
| Mar 2, 2026 | Flynn Sean C.Chief Legal Officer | Sell | 15,000 | $35.36 | $530K |
| Mar 2, 2026 | Halpin MichaelChief Operating Officer | Sell | 10,305 | $35.30 | $364K |
| Mar 2, 2026 | Flynn Sean C.Chief Legal Officer | Sell | 6,421 | $34.75 | $223K |
| Feb 11, 2026 | Mclaughlin Kevin FDirector | Sell | 7,000 | $34.66 | $243K |
| Jan 7, 2026 | Halpin MichaelChief Operating Officer | Sell | 10,000 | $40.48 | $405K |
| Dec 3, 2025 | Wotton Paul KDirector | Sell | 2,500 | $37.83 | $95K |
| Dec 2, 2025 | Wotton Paul KDirector | Sell | 2,500 | $37.97 | $95K |
| Dec 2, 2025 | Hopper Jonathan MarkChief Medical Officer | Sell | 1,652 | $39.14 | $65K |
| Nov 11, 2025 | Halpin MichaelChief Operating Officer | Sell | 2,642 | $40.41 | $107K |
| Nov 10, 2025 | Mclaughlin Kevin FDirector | Sell | 7,000 | $38.59 | $270K |
| Nov 6, 2025 | Halpin MichaelChief Operating Officer | Sell | 7,358 | $40.47 | $298K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.